Efficacy Study of Thalidomide in Gastrointestinal Vascular Malformation Related Bleeding

NCT02754960 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Gastrointestinal Hemorrhage
Vascular Malformation

Interventions

DRUG: Thalidomide
DRUG: Placebo

Sponsor

Shanghai Jiao Tong University School of Medicine